---
schema_version: "secwatch.filing_event.v1"
accession: "0001380106-26-000007"
form_type: "8-K"
ticker: "RPID"
cik: "0001380106"
company_name: "RAPID MICRO BIOSYSTEMS, INC."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:38:30.838587+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rapid Micro Biosystems pre-announces record Q4 rev $11.3M (+37% YoY); FY rev $33.6M (+20%)

## Summary
- Q4 2025 total revenue expected ~$11.3M, up ~37% YoY; record multi-system order from Top 20 biopharma customer.
- Full year 2025 revenue expected ~$33.6M, up ~20% YoY; recurring revenue $17.8M (+15%).
- Q4 placed 16 new Growth Direct systems, validated 3 customer systems; full year placed 28 and validated 18.
- Cumulative installed base: 190 systems globally, 155 validated.
- Company to announce complete FY2025 results and 2026 outlook later in Q1 2026.

## SEC filing metadata
- accession: 0001380106-26-000007
- form_type: 8-K
- ticker: RPID
- cik: 0001380106
- company_name: RAPID MICRO BIOSYSTEMS, INC.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/0001380106-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/rpid-20260113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001380106-26-000007
- JSON: https://secwatch.observer/filing/0001380106-26-000007.json
- Plain text: https://secwatch.observer/filing/0001380106-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.